Results

Total Results: 2,078 records

Showing results for "drugs".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-fracture-pain_consumer.pdf
    May 01, 2011 - Some common names for these drugs are morphine, codeine, and oxycodone. … Nonsteroidal anti-inflammatory drugs or NSAIDs. … Some common names for these drugs are ibuprofen and naproxen.
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-193-naloxone-executive-summary.pdf
    November 01, 2017 - characteristics (e.g., age, type and dose of opioid involved in overdose, or involvement of other drugs … in overdose, response to naloxone (e.g., based on Glasgow Coma Scale score), other substances and drugs … Amphastar Pharmaceuticals. FDA Advisory Committee Briefing Materials. … Amphastar Pharmaceuticals. … opioide overdose 2016. http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/Drugs
  3. effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1412.pdf
    December 22, 2014 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Telaprevir’s manufacturer, Vertex Pharmaceuticals, withdrew the drug from the market in September 2014 … Viekira Pak: The Viekira Pak (AbbVie, North Chicago, IL, and Enanta Pharmaceuticals, Inc., Watertown … In 2013, the plan spent $377 million for pharmaceuticals for all of its 600,000 members. 7 Oregon … Cambridge (MA): Vertex Pharmaceuticals; 2011 May. 23 p. 3. Ferenci P.
  4. effectivehealthcare.ahrq.gov/health-topics/diabetes-0
    August 04, 2010 - Series Overview February 15, 2011 Data Points #9: Utilization of antidiabetic drugs
  5. effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1412.pdf
    February 01, 2015 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Results The table below lists the two topics for which (1) preliminary phase III data for drugs were … Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease. … CNS Drugs. 2014 Dec;28(12):1185-9. … CNS Drugs. 2013 Jul;27(7):505-14. Also available: http://dx.doi.org/10.1007/s40263- 013-0076-8.
  6. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-evidence-exists-for-programs-to-increase-patient-adherence-to-prescription-medications-which-programsapproaches-are-most-effective-at-increasing-adherence-for-which-populations-and-conditions-if-little-or-no-evidence-exi
    August 12, 2009 - no If yes, explain the specific technologies, devices, drugs, or interventions you would like to … “Drugs don’t work in patients who don’t take them.” C. Everett Koop, M.D.
  7. effectivehealthcare.ahrq.gov/products/bipolar-disorder-treatment/final-report-2018
    August 07, 2018 - We synthesized evidence from 157 unique studies, 108 studies for 28 drugs, 49 studies for nondrug interventions … For drugs not approved for BD, paliperidone improved acute mania compared to placebo (low-strength evidence
  8. S131 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s131.pdf
    October 01, 2007 - Patients With the Same Treatment Indication: “Alternative Drug Users” Selecting comparison drugs that … have the same per- ceived medical indication for head-to-head comparisons of active drugs will reduce … In studies of the effectiveness of drugs, it is question- able whether to include patients who have a … In routine care, adherence to drugs is unfortunately substantially lower than in RCTs. … Selective prescribing can lead to over-estimation of the benefits of lipid-lowering drugs.
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
    March 01, 2013 - Oral DMARDs Anti-­‐tumor  necrosis  factor  drugs  vs.   … Oral DMARDs Anti-tumor necrosis factor drugs vs. … Oral DMARDs Anti-tumor necrosis factor drugs vs. … Oral DMARDs Anti-tumor necrosis factor drugs vs. … Oral DMARDs Anti-tumor necrosis factor drugs vs.
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
    March 01, 2013 - Oral DMARDs Anti-­‐tumor  necrosis  factor  drugs  vs.   … Oral DMARDs Anti-tumor necrosis factor drugs vs. … Oral DMARDs Anti-tumor necrosis factor drugs vs. … Oral DMARDs Anti-tumor necrosis factor drugs vs. … Oral DMARDs Anti-tumor necrosis factor drugs vs.
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_surveillance.pdf
    March 01, 2013 - Study did not compare specific drugs. … Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid … Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis … Evidence Table Author, Year Study Design Study name Drugs Year conducted N, Population F/U … Author, Year Study Design Study name Drugs Year conducted N, Population F/U Length Efficacy
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-summary.pdf
    November 01, 2023 - update for baclofen and 7 new trials for topiramate, and a small number of studies reported on some drugs … With the help of our technical expert panel, we limited drugs with off-label uses to those that are … Therefore, some drugs reviewed as emerging therapies and some only available outside the United States … In terms of results, our assessment of the effects of those drugs with Food and Drug Administration
  13. effectivehealthcare.ahrq.gov/products/rheumatoid-arthritis-medicine-update/final-report-update-2018
    July 16, 2018 - discontinuations because of adverse events may not differ between any disease-modifying antirheumatic drugs … and summary tables within and between corticosteroids and classes of disease-modifying antirheumatic drugs
  14. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Results The table below lists the three topics for which (1) preliminary phase III data for drugs or … Safety of antiobesity drugs. Ther Adv Drug Saf. 2013;4(4):171-81. … Anti- obesity drugs: Past, present and future. Dis Model Mech. 2012 Sep;5(5):621-6.
  15. S81 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s81.pdf
    October 01, 2007 - Nurses coded causative drugs into major classes. … Fewer classes of drugs commonly cause bleeding. … to these mechanisms are warfa- rins, heparins, antiplatelet agents, nonsteroidal anti-inflam- matory drugs … We derived a list of codes reflecting indications where guidelines17,18 dictate the use of drugs that … Development of models was greatly facilitated by focusing on the group estimated to be exposed to drugs
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-208-bipolar-evidence-summary.pdf
    August 01, 2018 - Some drugs aim to reduce symptoms associated with acute manic or mixed mania/depression episodes, some … For drugs not approved for BD, paliperidone also improved acute mania compared to placebo (low-strength … a number of observational studies being excluded, including those that looked at broad classes of drugs … , or individual drugs across broad populations. … However, none of the drugs reached MID.
  17. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/the-american-college-of-chest-physicians-accp-proposes-to-update-the-following-4-guideline-topics-from-the-2006-publication-on-the-diagnosis-and-management-of-cough-accp-evidence-based-clinical-practice-guidelines1-1-assessin
    January 01, 2006 - yes If yes, explain the specific technologies, devices, drugs, or interventions you would like to … Complications caused by coughing as well as adverse drugs reactions due to cough suppressants or protussive … manage the unexplained, refractory chronic cough in adults, and 4) to know which cough antisuppressant drugs
  18. effectivehealthcare.ahrq.gov/sites/default/files/pulmonary_hi_impact.pdf
    April 01, 2012 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … The table below lists the three topics for which (1) preliminary phase III were available for drugs … Impact Interventions Report, we aggregated related topics for summary and discussion (e.g., individual drugs
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gaps-pain-management.pdf
    January 01, 2023 - Some opioids may be less effective than other drugs. … Key Messages • Opioids are probably less effective than nonsteroidal anti-inflammatory drugs (NSAIDs … by the Centers for Disease Control and Prevention, evaluates the benefits and harms of nonopioid drugs … Key Messages As initial therapy in the prehospital setting: • Nonsteroidal anti-inflammatory drugs … Key Messages As initial therapy in the prehospital setting:  Nonsteroidal anti-inflammatory drugs
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioids-oa-protocol.pdf
    June 29, 2019 - many older adults are unable to tolerate non-opioid analgesics (e.g., non-steroidal anti-inflammatory drugs … Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction … Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase … A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs … Meta-analysis of dyspepsia and nonsteroidal antiinflammatory drugs.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: